The findings show that the molecular mechanisms of fucoidan in underlying atherosclerosis reduce lipid accumulation and promote cholesterol efflux via activation of ABCA1 through LXR-α in THP1 macrophage-derived foam cells. This evidence concerns the gene ABCA1 and atherosclerosis.